Vir Biotechnology to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Rhea-AI Summary

Vir Biotechnology (NASDAQ: VIR) has announced that its CEO Marianne De Backer will participate in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference in Miami, Florida. The event is scheduled for Tuesday, December 3, at 6:10 a.m. PT / 9:10 a.m. ET. A live webcast of the discussion will be available on the company's website under the Investors section and will remain accessible for 30 days following the event.

SAN FRANCISCO--(BUSINESS WIRE)-- Vir Biotechnology Inc. (NASDAQ: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, is scheduled to participate in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference on Tuesday December 3, at 6:10 a.m. PT / 9:10 a.m. ET in Miami, Florida.

A live webcast of the fireside chat will be made available under Events & Presentations in the Investors section of the Vir Biotechnology website at www.vir.bio and will be archived there for 30 days.

About Vir Biotechnology, Inc.

Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Vir Biotechnology’s clinical-stage portfolio includes infectious disease programs for chronic hepatitis delta and chronic hepatitis B infections and programs across several clinically validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies. Vir Biotechnology routinely posts information that may be important to investors on its website.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241125578049/en/

Media

Arran Attridge

Senior Vice President, Corporate Communications

aattridge@vir.bio

Investors

Richard Lepke

Senior Director, Investor Relations

rlepke@vir.bio

Source: Vir Biotechnology, Inc.

FAQ

When is Vir Biotechnology (VIR) presenting at the Evercore ISI HealthCONx Conference?

Vir Biotechnology is presenting on Tuesday, December 3, at 6:10 a.m. PT / 9:10 a.m. ET.

Where can I watch Vir Biotechnology's (VIR) Evercore Conference presentation?

The presentation can be viewed via live webcast in the Events & Presentations section of Vir Biotechnology's website (www.vir.bio) and will be archived for 30 days.

Who is representing Vir Biotechnology (VIR) at the Evercore HealthCONx Conference?

Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer of Vir Biotechnology, will represent the company in a fireside chat.

Where is the 7th Annual Evercore ISI HealthCONx Conference being held for VIR's presentation?

The conference is being held in Miami, Florida.